Sample nature | Derived from primary tumor or metastatis | % of mouse cells | PECAM1 | ENG | VEGFR1 | VEGFR2 | VEGFA | % of mVegfavs human + mouse VEGFA transcripts | |||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 |  |  | Hs | Mm | Hs | Mm | Hs | Mm | Hs | Mm | Hs | Mm |  |
Pure human control | Â | 0% | 1265 | 0 | 796 | 0 | 2610 | 0 | 157 | 0 | 287 | 0 | Â |
Pure mouse control | Â | 100% | 0 | 1176 | 0 | 736 | 0 | 303 | 0 | 879 | 0 | 790 | Â |
Colorectal carcinoma PDX | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
CRC#1 | Primary | 11% | 0 | 894 | 2 | 492 | 23 | 453 | 0 | 405 | 4010 | 212 | 5% |
CRC#2 | Primary | 5% | 0 | 917 | 3 | 398 | 9 | 383 | 0 | 309 | 4912 | 51 | 1% |
CRC#3 | Metastasis | 21% | 1 | 2380 | 34 | 893 | 14 | 843 | 0 | 803 | 4642 | 628 | 12% |
CRC#4 | Primary | 17% | 0 | 836 | <1 | 285 | 0 | 368 | 0 | 299 | 2876 | 302 | 10% |
CRC#5 | Metastasis | 8% | 0 | 813 | 0 | 492 | 3 | 337 | 0 | 374 | 3552 | 109 | 3% |
CRC#6 | Primary | 9% | 46 | 458 | 217 | 326 | 77 | 196 | <1 | 176 | 1866 | 84 | 4% |
CRC#7 | Metastasis | 8% | 17 | 553 | 27 | 272 | 65 | 292 | 0 | 210 | 5230 | 251 | 5% |
CRC#8 | Primary | 14% | 0 | 1193 | 469 | 614 | 3 | 349 | 0 | 689 | 2999 | 92 | 3% |
CRC#9 | Primary | 8% | 0 | 967 | 8 | 550 | 3 | 475 | 0 | 379 | 7973 | 204 | 2% |
CRC#10 | Primary | 10% | 0 | 733 | <1 | 409 | 176 | 246 | 0 | 284 | 3463 | 124 | 3% |
CRC#11 | Metastasis | 9% | 1 | 1083 | <1 | 481 | 300 | 567 | 0 | 410 | 5461 | 135 | 2% |
CRC#12 | Metastasis | 4% | 48 | 479 | 0 | 182 | 26 | 274 | 0 | 230 | 4937 | 106 | 2% |
CRC#13 | Metastasis | 4% | 3 | 356 | 5 | 135 | 289 | 163 | 0 | 168 | 3606 | 145 | 4% |
CRC#14 | Primary | 2% | <1 | 260 | 7 | 139 | 305 | 119 | 0 | 143 | 5085 | 76 | 1% |
CRC#15 | Primary | 17% | <1 | 1287 | <1 | 715 | 51 | 530 | 0 | 419 | 6541 | 311 | 5% |
CRC#16 | Metastasis | 5% | <1 | 477 | 44 | 237 | 89 | 197 | 0 | 219 | 3406 | 196 | 5% |
CRC#17 | Primary | 17% | 21 | 1067 | 49 | 539 | 42 | 382 | 0 | 323 | 3674 | 555 | 13% |
CRC#18 | Primary | 14% | 4 | 1078 | 81 | 550 | 33 | 370 | <1 | 356 | 2016 | 262 | 12% |
CRC#19 | Primary | 4% | 3 | 288 | <1 | 162 | <1 | 120 | 0 | 135 | 4258 | 111 | 3% |
CRC#20 | Metastasis | 22% | 4 | 1580 | 19 | 754 | 10 | 584 | <1 | 684 | 5604 | 391 | 7% |
CRC#21 | Metastasis | 17% | 10 | 1336 | 373 | 749 | 10 | 656 | 0 | 639 | 4894 | 432 | 8% |
CRC#22 | Primary | 18% | 0 | 2315 | 322 | 1081 | 32 | 908 | 0 | 1262 | 4671 | 1244 | 21% |
CRC#23 | Metastasis | 8% | 0 | 446 | 407 | 406 | 42 | 202 | 0 | 173 | 2360 | 155 | 6% |
CRC#24 | Primary | 12% | 0 | 981 | 5 | 581 | 13 | 508 | 0 | 331 | 4773 | 233 | 5% |
CRC#25 | Primary | 5% | 0 | 622 | 36 | 329 | 0 | 246 | 0 | 285 | 2643 | 68 | 3% |
CRC#26 | Primary | 11% | 0 | 1245 | 569 | 480 | 112 | 375 | 0 | 296 | 3607 | 237 | 6% |
CRC#27 | Primary | 14% | 4 | 1789 | 3 | 895 | 83 | 682 | 0 | 581 | 3101 | 891 | 22% |
CRC#28 | Carcinosis | 5% | 3 | 526 | 1 | 326 | 1 | 215 | 0 | 268 | 2545 | 29 | 1% |
CRC#29 | Primary | 11% | 5 | 1000 | 2 | 541 | 0 | 364 | 0 | 344 | 3172 | 391 | 11% |
CRC#30 | Primary | 7% | 0 | 753 | 11 | 332 | 22 | 282 | 0 | 258 | 2247 | 231 | 9% |
CRC#31 | Metastasis | 10% | <1 | 629 | 1 | 294 | 29 | 241 | 0 | 216 | 2896 | 210 | 7% |
CRC#32 | Primary | 16% | 0 | 1073 | 304 | 556 | 28 | 357 | 0 | 469 | 1731 | 166 | 9% |
CRC#33 | Primary | 7% | 4 | 563 | <1 | 277 | 7 | 202 | 0 | 218 | 1253 | 129 | 9% |
CRC#34 | Primary | 13% | 2 | 749 | 379 | 530 | 15 | 306 | 0 | 390 | 4293 | 157 | 4% |
CRC#35 | Primary | 9% | 0 | 958 | 3 | 484 | 9 | 329 | 0 | 318 | 2206 | 212 | 9% |
CRC#36 | Primary | 21% | 1 | 991 | 0 | 504 | 32 | 388 | <1 | 436 | 3296 | 140 | 4% |
CRC#37 | Primary | 19% | 6 | 1978 | 16 | 840 | 10 | 391 | 0 | 668 | 2692 | 182 | 6% |
CRC#38 | Primary | 8% | 2 | 1114 | 8 | 446 | 2 | 320 | 0 | 367 | 1889 | 218 | 10% |
CRC#39 | Metastasis | 12% | 0 | 1156 | 478 | 523 | 40 | 366 | 0 | 418 | 4034 | 214 | 5% |
CRC#40 | Primary | 10% | <1 | 547 | 94 | 356 | 49 | 199 | 0 | 242 | 1848 | 142 | 7% |
CRC#41 | Carcinosis | 16% | 0 | 1552 | 3 | 762 | 7 | 325 | 0 | 457 | 918 | 228 | 20% |
CRC#42 | Primary | 31% | 0 | 1786 | <1 | 922 | 94 | 447 | 0 | 599 | 2710 | 493 | 15% |
CRC#43 | Primary | 10% | 0 | 1024 | 75 | 459 | 249 | 358 | 2 | 431 | 4126 | 272 | 6% |
CRC#44 | Carcinosis | 15% | <1 | 938 | 159 | 565 | 1 | 285 | 0 | 364 | 2523 | 269 | 10% |
CRC#45 | Primary | 12% | 1654 | 807 | 512 | 388 | 9 | 215 | 1 | 332 | 969 | 124 | 11% |
CRC#46 | Primary | 3% | <1 | 412 | 3 | 158 | 2 | 139 | 0 | 168 | 1865 | 61 | 3% |
CRC#47 | Metastasis | 6% | 0 | 521 | 2 | 252 | <1 | 173 | 0 | 195 | 1662 | 68 | 4% |
CRC#48 | Carcinosis | 10% | 0 | 843 | <1 | 417 | 0 | 252 | 0 | 252 | 1705 | 227 | 12% |
CRC#49 | Metastasis | 6% | 1 | 379 | 426 | 274 | 11 | 248 | 0 | 267 | 4587 | 149 | 3% |
CRC#50 | Metastasis | 18% | 31 | 1697 | 0 | 690 | 23 | 485 | 0 | 421 | 5271 | 299 | 5% |
CRC#51 | Primary | 23% | 0 | 1294 | 2 | 662 | 67 | 476 | 0 | 375 | 6660 | 583 | 8% |
CRC#52 | Primary | 38% | 14 | 3265 | 398 | 1126 | 640 | 736 | 0 | 836 | 7517 | 953 | 11% |
CRC#53 | Metastasis | 19% | 0 | 1657 | 0 | 566 | 15 | 430 | 0 | 430 | 4014 | 209 | 5% |
Median | Â | 10.6% | 0.7 | 958 | 7 | 484 | 22 | 349 | 0 | 344 | 3463 | 210 | 6% |
Ovarian carcinoma PDX | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
OVC#1 | Metastasis | 28% | 42 | 2575 | 0 | 1498 | 89 | 1191 | 159 | 867 | 10390 | 459 | 4% |
OVC#2 | Metastasis | 5% | 4 | 565 | 99 | 350 | 2 | 439 | 34 | 259 | 6391 | 88 | 1% |
OVC#3 | Metastasis | 21% | 1 | 1427 | 304 | 809 | 69 | 406 | <1 | 583 | 3133 | 710 | 18% |
OVC#4 | Primary | 6% | 26 | 709 | 9 | 474 | 0 | 259 | 4 | 272 | 1528 | 144 | 9% |
OVC#5 | Primary | 7% | 16 | 974 | 81 | 807 | 0 | 802 | 45 | 525 | 14226 | 95 | 1% |
OVC#6 | Primary | 12% | 3 | 2052 | 97 | 593 | 19 | 734 | 101 | 528 | 2628 | 427 | 14% |
OVC#7 | Primary | 8% | 0 | 762 | 4 | 470 | 0 | 270 | 32 | 278 | 6156 | 266 | 4% |
OVC#8 | Primary | 3% | 2 | 219 | 30 | 119 | 6 | 88.8 | 3 | 59.2 | 652 | 37 | 5% |
OVC#9 | Primary | 8% | 5 | 1795 | 2 | 674 | 3 | 518 | 5 | 372 | 2981 | 184 | 6% |
OVC#10 | Primary | 4% | 1 | 444 | 16 | 288 | 0 | 204 | 22 | 141 | 2812 | 52 | 2% |
OVC#11 | Primary | 20% | 24 | 1586 | 54 | 1036 | 0 | 482 | 2 | 648 | 2781 | 493 | 15% |
OVC#12 | Primary | 13% | 3 | 877 | 177 | 487 | 0 | 259 | 12 | 285 | 1720 | 127 | 7% |
OVC#13 | Primary | 3% | 17 | 550 | 207 | 263 | 2 | 196 | <1 | 224 | 1134 | 16 | 1% |
OVC#14 | Primary | 5% | 0 | 332 | <1 | 255 | 21 | 238 | <1 | 164 | 19239 | 62 | 0% |
Median | Â | 7% | 3.7 | 819 | 42 | 480 | 2 | 338 | 9 | 281 | 2896 | 136 | 5% |
Glioblastoma PDX | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
GBM#1 | Primary | 8% | 22 | 712 | 2051 | 457 | 378 | 559 | 8 | 186 | 18822 | 241 | 1% |
GBM#2 | Primary | 13% | 1 | 1351 | 1143 | 819 | 0 | 799 | 378 | 328 | 17084 | 296 | 2% |
GBM#3 | Primary | 13% | 1 | 2372 | 422 | 1184 | 0 | 1325 | 0 | 1237 | 8452 | 131 | 2% |
GBM#4 | Primary | 5% | 55 | 870 | 321 | 328 | 0 | 503 | 0 | 372 | 5923 | 78 | 1% |
GBM#5 | Primary | 15% | 0 | 2600 | 268 | 1389 | 28 | 1361 | 294 | 1413 | 15443 | 100 | 1% |
Median | Â | 13% | 1.4 | 1351 | 422 | 819 | 0 | 799 | 8 | 372 | 15443 | 131 | 1% |
Breast cancer carcinoma PDX | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
BC#1 | Primary | 2% | <1 | 222 | 204 | 113 | 3 | 89.4 | 2 | 80.7 | 637 | 114 | 15% |
BC#2 | Primary | 8% | 0 | 666 | 177 | 335 | 19 | 289 | 0 | 162 | 2997 | 310 | 9% |
BC#3 | Metastasis | 10% | 0 | 679 | 286 | 447 | 5 | 539 | 36 | 259 | 4961 | 334 | 6% |
BC#4 | Primary | 15% | 46 | 803 | 91 | 498 | 5 | 366 | 0 | 222 | 3547 | 447 | 11% |
BC#5 | Primary | 1% | <1 | 116 | 0 | 61.9 | 33 | 89.1 | 4 | 31.9 | 15066 | 77 | 1% |
BC#6 | Metastasis | 15% | 2 | 1351 | 289 | 634 | 29 | 719 | 150 | 439 | 17360 | 357 | 2% |
BC#7 | Primary | 22% | 8 | 1908 | 442 | 887 | 0 | 1370 | 0 | 739 | 27659 | 365 | 1% |
BC#8 | Primary | 6% | 1 | 810 | 149 | 412 | 18 | 327 | 9 | 280 | 8360 | 160 | 2% |
BC#9 | Metastasis | 10% | 0 | 713 | 6 | 322 | 13 | 420 | 0 | 279 | 1020 | 294 | 22% |
BC#10 | Primary | 6% | 3 | 370 | 460 | 233 | 0 | 325 | 17 | 134 | 7447 | 154 | 2% |
BC#11 | Primary | 6% | 6 | 993 | 347 | 403 | 29 | 461 | 68 | 325 | 14282 | 256 | 2% |
BC#12 | Primary | 8% | 6 | 1005 | 466 | 543 | 28 | 664 | 3 | 391 | 25794 | 363 | 1% |
BC#13 | Primary | 7% | 0 | 575 | 92 | 256 | 8 | 266 | 15 | 189 | 6174 | 132 | 2% |
BC#14 | Primary | 8% | 654 | 745 | 45 | 413 | 0 | 279 | 2 | 253 | 3294 | 71 | 2% |
BC#15 | Metastasis | 11% | 4 | 912 | 50 | 461 | 1 | 311 | 0 | 286 | 3458 | 186 | 5% |
BC#16 | Primary | 2% | 0 | 199 | 188 | 94.6 | 4 | 73.6 | 2 | 69.7 | 610 | 100 | 14% |
BC#17 | Primary | 4% | 13 | 413 | 346 | 134 | 66 | 173 | 32 | 101 | 2131 | 197 | 8% |
BC#18 | Primary | 10% | <1 | 1545 | 168 | 743 | 3 | 788 | 11 | 382 | 6550 | 167 | 2% |
BC#19 | Metastasis | 16% | <1 | 2304 | 167 | 1188 | 5 | 1049 | 10 | 771 | 6004 | 280 | 4% |
BC#20 | Primary | 17% | 0 | 1967 | 340 | 959 | 1 | 709 | 20 | 634 | 11533 | 357 | 3% |
BC#21 | Primary | 9% | 0 | 730 | 334 | 332 | 2 | 476 | 91 | 202 | 8166 | 520 | 6% |
BC#22 | Primary | 6% | 0 | 598 | 451 | 222 | 10 | 334 | 90 | 124 | 5088 | 264 | 5% |
BC#23 | Primary | 4% | 0 | 377 | 331 | 179 | 2 | 195 | 19 | 83.3 | 1742 | 51 | 3% |
BC#24 | Primary | 22% | 1 | 1128 | 858 | 982 | 79 | 999 | <1 | 495 | 21363 | 668 | 3% |
BC#25 | Primary | 10% | 0 | 1165 | 666 | 573 | 94 | 627 | 12 | 474 | 14542 | 244 | 2% |
BC#26 | Primary | 10% | 0 | 1446 | 429 | 572 | 0 | 685 | 230 | 510 | 5771 | 257 | 4% |
BC#27 | Primary | 14% | 2 | 880 | 4 | 452 | 94 | 415 | <1 | 222 | 1505 | 299 | 17% |
BC#28 | Primary | 5% | <1 | 182 | 91 | 113 | 7 | 119 | 6 | 80.3 | 1221 | 50 | 4% |
BC#29 | Primary | 9% | <1 | 656 | 530 | 469 | 32 | 532 | 9 | 473 | 50360 | 255 | 1% |
BC#30 | Primary | 7% | 3 | 823 | 94 | 341 | 247 | 403 | 34 | 244 | 9097 | 373 | 4% |
BC#31 | Primary | 4% | 0 | 345 | 166 | 216 | 0 | 161 | 3 | 145 | 1085 | 79 | 7% |
BC#32 | Primary | 7% | <1 | 629 | 13 | 276 | 4 | 237 | 19 | 194 | 1544 | 198 | 11% |
BC#33 | Primary | 9% | <1 | 725 | 397 | 428 | 232 | 549 | 6 | 231 | 5414 | 144 | 3% |
BC#34 | Primary | 14% | 5 | 1061 | 245 | 557 | 0 | 457 | 0 | 308 | 3866 | 176 | 4% |
BC#35 | Primary | 5% | 2 | 484 | 103 | 358 | 3 | 506 | 50 | 185 | 23896 | 360 | 1% |
BC#36 | Primary | 13% | 0 | 1085 | 221 | 544 | 0 | 333 | 13 | 347 | 1153 | 231 | 17% |
BC#37 | Primary | 4% | 0 | 376 | 193 | 149 | <1 | 144 | 13 | 120 | 1081 | 289 | 21% |
BC#38 | Primary | 6% | 2 | 776 | 90 | 415 | 8 | 326 | 12 | 281 | 4683 | 178 | 4% |
BC#39 | Primary | 14% | 0 | 961 | 5 | 731 | 83 | 691 | 4 | 606 | 4829 | 152 | 3% |
Median | Â | 7.9% | 0.7 | 745 | 193 | 413 | 5 | 403 | 10 | 253 | 5088 | 244 | 4% |
Cutaneous melanoma PDX | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
CM#1 | Metastasis | 11% | 0 | 1725 | 2985 | 825 | 0 | 953 | 83 | 1026 | 10386 | 1401 | 12% |
CM#2 | Metastasis | 7% | 27 | 544 | 1391 | 426 | 768 | 360 | 0 | 184 | 10696 | 315 | 3% |
CM#3 | Metastasis | 4% | 1 | 282 | 257 | 180 | 0 | 122 | 1 | 155 | 599 | 102 | 14% |
CM#4 | Primary | 20% | 0 | 3306 | 784 | 1178 | 427 | 883 | 38 | 836 | 9188 | 718 | 7% |
CM#5 | Metastasis | 8% | 9 | 936 | 872 | 363 | 15 | 587 | 0 | 289 | 5590 | 201 | 3% |
CM#6 | Metastasis | 3% | <1 | 342 | 648 | 196 | 6 | 188 | 5 | 236 | 960 | 23 | 2% |
CM#7 | Metastasis | 1% | 2 | 176 | 382 | 83.6 | 2 | 135 | <1 | 84.3 | 5962 | 37 | 1% |
CM#8 | Primary | 10% | 9 | 4760 | 876 | 705 | 0 | 2230 | 5 | 841 | 16732 | 239 | 1% |
CM#9 | Metastasis | 1% | 0 | 118 | 284 | 61.6 | 20 | 125 | 14 | 73.6 | 3704 | 24 | 1% |
CM#10 | Primary | 10% | 0 | 876 | 756 | 300 | 0 | 248 | 279 | 285 | 387 | 126 | 25% |
CM#11 | Metastasis | 8% | 2 | 641 | 1102 | 427 | 0 | 355 | 1 | 309 | 8837 | 266 | 3% |
CM#12 | Primary | 5% | 0 | 530 | 112 | 186 | 0 | 440 | 0 | 423 | 683 | 26 | 4% |
CM#13 | Metastasis | 2% | <1 | 243 | 145 | 101 | <1 | 116 | 1 | 82.2 | 466 | 31 | 6% |
Median | Â | 7.1% | 0.9 | 544 | 756 | 300 | 0.8 | 355 | 1 | 285 | 5590 | 126 | 3% |
Renal cell carcinoma PDX | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
RCC#1 | Primary | 17% | 0 | 1179 | 569 | 1002 | 0 | 680 | 2 | 473 | 19769 | 1513 | 7% |
RCC#2 | Primary | 12% | 0 | 3362 | 16 | 1929 | 0 | 1934 | 0 | 3043 | 27096 | 54 | 0% |
RCC#3 | Primary | 27% | 0 | 5431 | 411 | 2376 | 0 | 1866 | 0 | 1974 | 25792 | 211 | 1% |
RCC#4 | Metastasis | 11% | 120 | 2117 | 256 | 1430 | 4 | 1512 | 0 | 1337 | 13968 | 89 | 1% |
RCC#5 | Primary | 16% | 5 | 2906 | 33 | 1942 | 3 | 1624 | 0 | 2102 | 25817 | 87 | 0% |
RCC#6 | Primary | 1% | 1 | 341 | 2 | 125 | 2 | 157 | 47 | 119 | 609 | 13 | 2% |
RCC#7 | Primary | 21% | 0 | 768 | 549 | 1908 | 0 | 1292 | 0 | 1324 | 27232 | 157 | 1% |
RCC#8 | Metastasis | 17% | 1 | 842 | 410 | 778 | 0 | 466 | 0 | 286 | 1756 | 930 | 35% |
RCC#9 | Metastasis | 13% | 17 | 2024 | 230 | 1258 | 3 | 827 | 1 | 904 | 37839 | 55 | 0% |
RCC#10 | Primary | 11% | 0 | 2010 | 856 | 1359 | 0 | 1070 | 2 | 672 | 37217 | 83 | 0% |
RCC#11 | Primary | 5% | 2 | 597 | 907 | 350 | 0 | 487 | 0 | 253 | 5091 | 136 | 3% |
RCC#12 | Metastasis | 14% | 0 | 2546 | 257 | 1132 | 0 | 871 | 0 | 1040 | 16952 | 61 | 0% |
RCC#13 | Primary | 21% | 0 | 4963 | 38 | 3466 | 0 | 3281 | 0 | 3966 | 30645 | 155 | 1% |
RCC#14 | Primary | 6% | 330 | 1338 | 364 | 602 | 0 | 661 | 2 | 343 | 26952 | 52 | 0% |
RCC#15 | Primary | 6% | 77 | 565 | 1036 | 293 | 0 | 368 | 0 | 291 | 2210 | 59 | 3% |
Median | Â | 12.9% | 1.2 | 2010 | 364 | 1258 | 0 | 871 | 0 | 904 | 25792 | 87 | 1% |
Lung carcinoma PDX | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Small cell lung carcinoma | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
SCLC#1 | Primary | 8% | 0 | 1030 | 3 | 387 | 0 | 250 | 0 | 196 | 419 | 43 | 9% |
SCLC#2 | Primary | 3% | 2 | 632 | 0 | 238 | 5 | 189 | 0 | 185 | 1300 | 52 | 4% |
SCLC#3 | Primary | 4% | 4 | 591 | 0 | 259 | 1 | 232 | 2 | 232 | 1117 | 49 | 4% |
SCLC#4 | Primary | 3% | 7 | 395 | 0 | 222 | 0 | 166 | 0 | 162 | 1498 | 46 | 3% |
SCLC#5 | Metastasis | 2% | 0 | 309 | 1 | 153 | 0 | 160 | 2 | 122 | 893 | 56 | 6% |
SCLC#6 | Primary | 7% | 2 | 670 | 9 | 221 | 471 | 208 | 72 | 192 | 954 | 86 | 8% |
Median | Â | 3.3% | 1.7 | 612 | 0 | 230 | 1 | 198 | 1 | 189 | 1035 | 51 | 5% |
Non small cell lung carcinoma | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | |
NSCLC#1 | Primary | 28% | 3 | 1969 | 61 | 941 | 2 | 1145 | 14 | 637 | 18440 | 794 | 4% |
NSCLC#2 | Primary | 8% | 0 | 1270 | 0 | 611 | 0 | 511 | 335 | 639 | 5911 | 98 | 2% |
NSCLC#3 | Primary | 22% | 95 | 1590 | 31 | 1438 | 124 | 961 | 930 | 669 | 18346 | 429 | 2% |
NSCLC#4 | Primary | 5% | 2 | 686 | 5 | 339 | 4 | 212 | 59 | 221 | 875 | 85 | 9% |
NSCLC#5 | Primary | 20% | 3 | 1363 | 667 | 1387 | 184 | 896 | 3106 | 652 | 10612 | 688 | 6% |
Median | Â | 20% | 2.7 | 1363 | 31 | 941 | 4 | 896 | 335 | 639 | 10612 | 429 | 4% |